[Durgical](https://durgical.com/en/) › [DurgiPedia](https://durgical.com/en/durgipedia/) › [Immunology](https://durgical.com/en/immunology/) › [Innate immunity](https://durgical.com/en/immunology/areas/innate/) › Macrophage activation: classical (M1) vs alternative (M2)

# Macrophage activation: classical (M1) vs alternative (M2)

- Process

The same macrophage can be a killer or a repairer: IFN-γ makes it kill microbes, IL-4 and IL-13 make it rebuild tissue.

Updated Nov 15, 2026

## Key points

- IFN-γ + LPS → classical (M1): NO, ROS, IL-12, TNF → kill intracellular microbes.
- IL-4/IL-13 → alternative (M2): arginase, TGF-β → repair and fibrosis.
- Granulomas need IFN-γ and TNF; anti-TNF reactivates TB.
- M1/M2 is a spectrum, not two lineages.

On this page

- The basics Key points
- What it is
- How to think about it
- Key facts
- Step by step
- Two ends of macrophage activation
- Common traps
- Memory aid
- Elsewhere in DurgiPedia

- Clinical Clinical notes

- Study Test yourself

- Connections Connections

## What it is

Macrophages change their programme according to the signals around them. Classical activation (M1-like) by IFN-γ and microbial products makes them kill intracellular microbes and drive inflammation. Alternative activation (M2-like) by IL-4 and IL-13 makes them repair tissue, lay down matrix and fight helminths. These are two ends of a spectrum, not two fixed cell types, and the balance shapes granulomas, fibrosis and tumours.

## How to think about it

Arginine is the fork in the road: classically activated macrophages burn it into [nitric oxide](https://durgical.com/en/pharmacology/nitric-oxide/) to kill, alternatively activated ones turn it into ornithine to build [collagen](https://durgical.com/en/biochemistry/enzymes/collagen/). The T cells around decide the turn (IFN-γ from Th1 → kill; IL-4 and IL-13 from Th2 → build), and because a macrophage can switch, M1 and M2 are the two ends of a spectrum, not two cell types.

## Key facts

- IFN-γ is the master activator of classical macrophages; IL-12 from macrophages in turn drives Th1 cells, a feed-forward loop.
- Arginine is the switch point: iNOS turns it into nitric oxide (killing), arginase turns it into ornithine (repair).
- Epithelioid cells and multinucleated giant cells of granulomas are macrophages chronically activated by IFN-γ and TNF.

## Step by step

- A Th1 or NK cell meets a macrophage harbouring microbes and releases IFN-γ.
- IFN-γ plus a TLR signal (such as LPS) switches on STAT1 and NF-κB in the macrophage.
- iNOS and [NADPH](https://durgical.com/en/biochemistry/molecules/nadph/) oxidase rise; nitric oxide and reactive [oxygen](https://durgical.com/en/pharmacology/oxygen/) species kill the ingested microbes.
- The activated macrophage releases IL-12 (more Th1), TNF and IL-1, amplifying the loop.
- If IL-4 and IL-13 dominate instead, arginase-1, TGF-β and growth factors drive repair and fibrosis.
- Chronic IFN-γ and TNF turn macrophages into epithelioid and giant cells that wall off persistent microbes in granulomas.

## Two ends of macrophage activation

| Feature | Classical (M1-like) | Alternative (M2-like) |
| --- | --- | --- |
| Main inducers | IFN-γ (Th1, NK cells) plus TLR ligands such as LPS | IL-4 and IL-13 (Th2, ILC2); also IL-10 and [glucocorticoids](https://durgical.com/en/physiology/actions-of-cortisol/) for regulatory types |
| Key enzymes and products | Inducible [nitric oxide synthase](https://durgical.com/en/biochemistry/enzymes/nitric-oxide-synthase/) (NO), reactive oxygen species, lysosomal enzymes | Arginase-1 (proline and [polyamines](https://durgical.com/en/biochemistry/topics/polyamines/) for collagen), growth factors |
| Cytokines released | IL-1, IL-12, TNF, IL-6, chemokines | IL-10, TGF-β, PDGF, VEGF |
| Main job | Kill intracellular microbes; inflammation | Tissue repair, fibrosis, [angiogenesis](https://durgical.com/en/physiology/long-term-flow-control-angiogenesis-collaterals-and-vascular-remodelling/), helminth defence |
| When it goes wrong | Tissue damage in chronic inflammation | Fibrosis; tumour-associated macrophages that help tumours grow |

## Clinical notes

- Defects in the IL-12/IFN-γ axis cause severe infections with weak [mycobacteria](https://durgical.com/en/microbiology/groups/mycobacteria/) (BCG, non-tuberculous mycobacteria).
- TNF blockers can reactivate [latent tuberculosis](https://durgical.com/en/conditions/latent-tuberculosis-infection/) because they weaken granuloma maintenance.
- Schistosome eggs drive a type 2 granuloma with alternatively activated macrophages and [liver](https://durgical.com/en/anatomy/liver/) fibrosis.
- Tumour-associated macrophages are often M2-like and promote angiogenesis and immune suppression.

## Common traps

- **M1 and M2 are two separate macrophage lineages**: they are states of the same cell along a spectrum, and a macrophage can switch as its signals change.
- **M2 macrophages are always the helpful ones**: they drive fibrosis (schistosomal liver) and, as tumour-associated macrophages, help tumours grow.
- **TNF blockers reactivate TB because they kill T cells**: they weaken granuloma maintenance, so walled-off bacilli escape; screen for latent TB first.
- **IL-10 is the main inducer of the repair macrophage**: IL-4 and IL-13 drive it, while IL-10 and glucocorticoids induce a regulatory, deactivated type.

## Memory aid

M1 is the Marine (kills), M2 is the Mason (builds); IFN-γ calls the Marine, IL-4 and IL-13 call the Mason.

## Test yourself

Think of the answer, then tap the question to see it.

## A child with an IFN-γ receptor defect develops disseminated infection after BCG vaccination. Why are mycobacteria the problem?

Mycobacteria live inside macrophages; without IFN-γ signalling the macrophage is never classically activated, so it cannot make the NO and ROS needed to kill them.

## Why do schistosome eggs cause liver fibrosis rather than abscesses?

The eggs drive a Th2 response; IL-4 and IL-13 alternatively activate macrophages, whose arginase, TGF-β and growth factors lay down collagen around the eggs.

## Why can TNF blockers reactivate latent tuberculosis?

TNF is needed to keep activated macrophages organised in granulomas that contain the bacilli.

[Add to my cards (3)](https://durgical.app/estudiar/?add=/en/immunology/macrophage-activation-classical-vs-alternative/)

## Elsewhere in DurgiPedia

- [Granulation tissue and scar formation](https://durgical.com/en/general-pathology/granulation-tissue-and-scar-formation/)
- [Fibrosis in organs: TGF-β and the myofibroblast](https://durgical.com/en/general-pathology/fibrosis-in-organs-tgf-and-the-myofibroblast/)
- [Chronic inflammation: causes, cells and features](https://durgical.com/en/general-pathology/chronic-inflammation-causes-cells-and-features/)

## Connections

## Related 8

- [Monocyte and macrophage](https://durgical.com/en/immunology/monocyte-and-macrophage/)
- [Interferon-γ](https://durgical.com/en/immunology/interferon/)
- [Th1, Th2, Th17, Tfh and Treg](https://durgical.com/en/immunology/th1-th2-th17-tfh-and-treg/)
- [Granulomatous inflammation](https://durgical.com/en/immunology/granulomatous-inflammation/)
- [IL-4, IL-5 and IL-13 (the Th2 cytokines)](https://durgical.com/en/immunology/il-4-il-5-and-il-13/)
- [IL-10 and TGF-β (the brakes)](https://durgical.com/en/immunology/il-10-and-tgf/)
- [Hyper-IgE (Job) syndrome, chronic mucocutaneous candidiasis and the IL-12/IFN-γ axis](https://durgical.com/en/immunology/hyper-ige-syndrome-chronic-mucocutaneous-candidiasis-and-the-il-12-ifn-axis/)
- [Tumor immunology and checkpoint inhibitors](https://durgical.com/en/immunology/tumor-immunology-and-checkpoint-inhibitors/)

## Related conditions 2

- [Tuberculosis](https://durgical.com/en/conditions/tuberculosis/)
- [Sarcoidosis](https://durgical.com/en/conditions/sarcoidosis/)

## Microorganisms 1

- [Mycobacterium tuberculosis](https://durgical.com/en/microbiology/mycobacterium-tuberculosis/)

[← All of immunology](https://durgical.com/en/immunology/)

Educational content on the immune system; not a treatment or individual vaccination guide and no substitute for a health professional's advice. No doses are given.

Sources: [Immune response](https://medlineplus.gov/ency/article/000821.htm) (MedlinePlus, US National Library of Medicine, 2024).

## **Spotted a mistake?** We are always improving for the community. Tell us what is wrong and our team will review it. Report a mistake

Representative model, for educational purposes only.

---
Source: https://durgical.com/en/immunology/macrophage-activation-classical-vs-alternative/
License: CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). Cite as: DurgiPedia (durgical.com), https://durgical.com/en/immunology/macrophage-activation-classical-vs-alternative/
